Synageva (GEVA) PT Raised to $124 at Nomura
Tweet
Share
E-mailGet Alerts GEVA Hot Sheet
Price: $238.60 --0%
Rating Summary:
6 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
6 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Nomura Securities analyst M. Ian Somaiya reiterated a Buy rating and raised his price target on Synageva BioPharma (NASDAQ: GEVA) to $124.00 (from $114.00).
The increased price target come as they roll valuation to YE15.
For an analyst ratings summary and ratings history on Synageva BioPharma click here. For more ratings news on Synageva BioPharma click here.
Shares of Synageva BioPharma closed at $94.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Camden Property Trust (CPT) PT Lowered to $108 at Truist Securities
- Akamai Technologies (AKAM) PT Raised to $149 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
